Interferon Treatments for SARS-CoV-2: Challenges and Opportunities-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Interferon Treatments for SARS-CoV-2: Challenges and Opportunities

Published:2022-04-21 Issue:3 Volume:11 Page:953-972
ISSN:2193-8229
Container-title:Infectious Diseases and Therapy
language:en
Short-container-title:Infect Dis Ther

Author:

Jhuti Diya,Rawat Angeli,Guo Christina M.,Wilson Lindsay A.,Mills Edward J.,Forrest Jamie I.

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases,Microbiology (medical)

Link

https://link.springer.com/content/pdf/10.1007/s40121-022-00633-9.pdf

Reference31 articles.

1. WHO Solidarity Trial Consortium. Repurposed antiviral drugs for Covid-19—interim WHO solidarity trial results. N Engl J Med. 2021;384:497–511.

2. Piper JM, Wen TT-S, Xenakis EM-J. Interferon therapy in primary care. Prim Care Update OBGYNS. 2001;8:163–9.

3. Blanco-Melo D, Nilsson-Payant BE, Liu W-C, et al. Imbalanced host response to SARS-CoV-2 drives development of COVID-19. Cell. 2020;181:1036-1045.e9.

4. Hadjadj J, Yatim N, Barnabei L, et al. Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients. Science. 2020;369:718–24.

5. Zhou Z, Ren L, Zhang L, et al. Heightened innate immune responses in the respiratory tract of COVID-19 patients. Cell Host Microbe. 2020;27:883-890.e2.

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inflammatory response to SARS-CoV 2 and other respiratory viruses;Expert Review of Anti-infective Therapy;2024-09-11

2. Multiple Mechanisms of Action of Sulfodyne®, a Natural Antioxidant, against Pathogenic Effects of SARS-CoV-2 Infection;Antioxidants;2024-09-04

3. STING agonists as promising vaccine adjuvants to boost immunogenicity against SARS-related coronavirus derived infection: possible role of autophagy;Cell Communication and Signaling;2024-06-03

4. Sustained IFN signaling is associated with delayed development of SARS-CoV-2-specific immunity;Nature Communications;2024-05-16

5. Intranasal neomycin evokes broad-spectrum antiviral immunity in the upper respiratory tract;Proceedings of the National Academy of Sciences;2024-04-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3